Annovis Bio - more positive news from PD,... - Cure Parkinson's

Cure Parkinson's

26,181 members27,513 posts

Annovis Bio - more positive news from PD, AD clinical trial . . .

redhawk1 profile image
4 Replies

Small trial but additional encouraging news for PD and AD communities . . . irpages2.eqs.com/websites/a...

Written by
redhawk1 profile image
redhawk1
To view profiles and participate in discussions please or .
Read more about...
4 Replies
faridaro profile image
faridaro

Very interesting - thanks for sharing!There is more information about this drug on Alzheimer's forum :

alzforum.org/therapeutics/p....

sharoncrayn profile image
sharoncrayn

weak PD clinical trial. Not sure why they used the WAIS for PD. They claim "It measures fine-motor dexterity, speed, accuracy and ability to manipulate a pencil and perceptual organization. " I always thought it MEASURED REASONING AND MEMORY (FOR ALZ, BUT NOT PD unless LB PD dementia). interesting.

for ALZ, filed for "orphan drug" status re: ALZ- DS (rare disease, minor occurrence) to avoid full drawn out review.

very strange that WAIS scores were the same for ALZ and PD non placebo cohorts. Wonder why. selection bias?

redhawk1 profile image
redhawk1 in reply to sharoncrayn

Always appreciate your reasoned assessment, Sharon. I did notice that Annovis timed their issuance of additional of additional stock for sale the day after releasing the positive clinical trial news! lol Price of a share of stock more than doubled after the good news!! Well, it takes a lot of money to finance a small biotech!

sharoncrayn profile image
sharoncrayn in reply to redhawk1

oh yea, ride that trick pony miss ceo.

Not what you're looking for?

You may also like...

ANNOVIS BIO ANNOUNCES POSITIVE FDA NOTICE FOR BUNTANETAP PHASE 3 CLINICAL TRIAL IN PARKINSON'S DISEASE

https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?airportNewsID=e4e0b40

Good news from Annovis (for Alzheimer's)

This just in my inbox! Good news for Annovis as it will give them time on Parkinsons! "Dear...

ANNOVIS BIO ANNOUNCES POSITIVE FDA FEEDBACK FOR BUNTANETAP PHASE 3 CLINICAL DEVELOPMENT IN PARKINSON'S DISEASE (ANVS401)

https://irpages2.eqs.com/websites/annovis/English/431010/us-press-release.html?releaseID=111474&d=20

Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease

This trial is already open in the United States, and I believe some on this forum are...

Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s Disease

Annovis Bio Announces First Patient Dosed in Phase 3 Trial in Patients with Early Parkinson’s...